Researchers have found in a new study that an eGFRcys value that is 30% or more lower than eGFRcr was associated with ...

Making medical policy based on racial stereotypes harmed all Black Americans waiting for a kidney. This lawsuit is brought by ...

Urinating more in winter is common, but not always harmless. A urologist explains why men experience frequent urination in ...

Vonafexor reversed a historical mean eGFR decline of -6.4 mL/min/1.73 m²/yr to a mean functional gain on-treatment of +4.8 mL/min/1.73 m²/yr from baseline 73% of patients maintained albuminuria ...

Disagreement between creatinine and cystatin C kidney tests signals a much higher risk of serious disease and death, ...

Preventive health check-ups in 2026 are essential for early disease detection and long-term well-being. Experts recommend ...

Kidney diseases are alarmingly increasing, now the ninth leading cause of death. Dr. Arjun Sabharwal highlights crucial tests like eGFR, Cystatin C, urine dipstick, and protein-to-creatinine ratio to ...

ASN Kidney Week, held in November, featured leading-edge science in kidney care, with evidence supporting new drugs to treat ...

The epidemiology of hypertension in India has undergone a malignant shift, moving from a disease of the elderly to a ...

Kidney disease often progresses silently, causing irreversible damage before symptoms appear. Simple tests like blood eGFR/creatinine, urine microalbumin (ACR), complete urine examination, and ...

Post hoc trial findings support aprocitentan’s potential cardiovascular and kidney-protective effects in patients with chronic kidney disease (CKD) with resistant hypertension.

Algorithms in clinical decision tools have been making it harder for certain racial and socioeconomic groups to receive the healthcare they deserve.